ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物科技指數ETF-iShares Nasdaq
216.40
+3.87
1.82%
盤前：
216.98
0.5800
+0.27%
05:32 EDT
成交量：
146.62萬
成交額：
3.17億
市值：
108.85億
市盈率：
34.28
高：
217.12
開：
213.40
低：
213.22
收：
212.53
52周最高：
217.12
52周最低：
137.09
股本：
5,030.00萬
流通股本：
5,030.00萬
量比：
0.69
換手率：
2.91%
股息：
0.41
股息率：
0.19%
每股收益(TTM):
6.31
每股收益(LYR):
-1.4940
淨資產收益率：
24.54%
總資產收益率：
0.10%
市淨率：
1.34
市盈率(LYR):
-144.85
資料載入中...
總覽
公司
新聞資訊
公告
吉利德科學(GILD)腫瘤組合療法獲歐洲藥品管理局旗下CHMP推薦
金吾财讯
·
07/24
CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌
美股速递
·
07/24
百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期
新浪医药
·
07/23
argenx(ARGX)二季度產品淨銷售額達15.16億美元 按年增長60%
金吾财讯
·
07/23
美國研究綜述-Alphabet、IBM、特斯拉
路透中文
·
07/23
數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法
路透中文
·
07/22
創新藥研發加速遇「猴荒」
三里河
·
07/22
吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒
路透中文
·
07/22
安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解
路透中文
·
07/21
Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元
美股速递
·
07/21
Leerink下調吉利德科學目標價至127美元
格隆汇
·
07/21
Kalshi將允許對臨床試驗和FDA決定進行投注
路透中文
·
07/16
三星生物製劑與歐加農將在澳大利亞推出新型生物類似藥。
智通财经
·
07/16
剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗
路透中文
·
07/14
Vertex(VRTX)百億美元收購罕見病藥企 拓寬內分泌管線佈局
金吾财讯
·
07/13
Pliant Therapeutics任命Flavia Borellini博士和Robert Iannone博士加入董事會
投资观察
·
07/13
RBC將Kymera Therapeutics的評級下調至「與行業持平」，並上調目標價
路透中文
·
07/13
英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作
新浪港股
·
07/13
福泰製藥百億美元併購透露了什麼訊號？
蓝鲸财经
·
07/11
吉利德科學(GILD)股票7月10日盤中下跌3.26%：關鍵驅動因素揭曉
TradingKey中文
·
07/11
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/hant/stock/IBB/news?page=6"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":216.4,"timestamp":1787688000000,"preClose":212.53,"halted":0,"volume":1466169,"hourTrading":{"tag":"盘前","latestPrice":216.98,"preClose":216.4,"latestTime":"05:32 EDT","volume":663,"amount":143714.81709,"timestamp":1787736733931,"change":0.58,"changeRate":0.00268,"amplitude":0.010835},"delay":0,"changeRate":0.018209193996141744,"floatShares":50300000,"shares":50300000,"eps":6.311863,"marketStatus":"盤前交易","change":3.87,"latestTime":"08-26 06:58:22 EDT","open":213.4,"high":217.12,"low":213.22,"amount":316799197.11812997,"amplitude":0.01835,"askPrice":217.78,"askSize":305,"bidPrice":202,"bidSize":5,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1787751000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":216.4,"sharesOutstanding":49450000,"nav":212.515646,"aum":10647033864.6,"dividendRate":0.0019,"bidAskSpread":0.000376,"preHourTrading":{"tag":"盘前","latestPrice":216.98,"preClose":216.4,"latestTime":"05:32 EDT","volume":663,"amount":143714.81709,"timestamp":1787736733931,"change":0.58,"changeRate":0.00268,"amplitude":0.010835},"postHourTrading":{"tag":"盘后","latestPrice":216,"preClose":216.4,"latestTime":"19:59 EDT","volume":19054,"amount":4123254.049,"timestamp":1787702394520,"change":-0.4,"changeRate":-0.001848,"amplitude":0.001848},"volumeRatio":0.6884603584689706,"impliedVol":0.2594,"impliedVolPercentile":0.86},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50300000,"roa":"0.10%","roe":"24.54%","lyrEps":-1.493977,"volumeRatio":0.6884603584689706,"shares":50300000,"dividePrice":0.4112,"high":217.12,"amplitude":0.01835,"preClose":212.53,"low":213.22,"week52Low":137.09,"pbRate":"1.34","psRate":"261.88","week52High":217.12,"institutionHeld":0,"latestPrice":216.4,"committee":-0.967742,"eps":6.311863,"divideRate":0.0019,"volume":1466169,"delay":0,"ttmEps":6.311863,"open":213.4,"prevYearClose":168.77,"prevWeekClose":213.56,"prevMonthClose":186.41,"prevQuarterClose":190.19,"fiveDayClose":203.56,"twentyDayClose":190.52,"sixtyDayClose":172.18},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"},{"date":"2025-03-18","symbol":"IBB","amount":0.121169,"announcedDate":"2025-03-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-18","defaultRemindTime":1742304600000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-21","payableDate":"2025-03-18","currency":"USD","dateTimestamp":1742270400000,"payDate":"2025-03-21"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:6,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653895100","title":"吉利德科學(GILD)腫瘤組合療法獲歐洲藥品管理局旗下CHMP推薦","url":"https://stock-news.laohu8.com/highlight/detail?id=2653895100","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653895100?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 18:45","pubTimestamp":1784889935,"startTime":"0","endTime":"0","summary":"金吾财讯 | 吉利德科学 宣布，欧洲药品管理局旗下人用药品委员会已发布积极意见，建议批准其Trop-2靶向ADC药物Trodelvy联合帕博利珠单抗，用于既往未接受过全身治疗、且肿瘤PD-L1表达阳性的不可切除局部晚期或转移性三阴性乳腺癌成人患者。若欧盟委员会于2026年晚些时候正式批准该联合疗法，Trodelvy将实现从单药到联合疗法、全面覆盖不同PD-L1表达状态的mTNBC一线治疗布局。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NmQ4YmNlMWEyMTYyODU5MDQwMjQzMA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302998","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU1571399168.USD","LU0965509010.AUD","LU1934455194.USD","LU2087621335.USD","MEDI","LU0965509101.SGD","LU1585245621.USD","BK4588","LU1037948541.HKD","LU0122379950.USD","LU2089984988.USD","BK4550","BBH","LU0823416689.USD","CHMP","TMED","SG9999015952.SGD","SG9999015986.USD","LU1057294990.SGD","IE00B19Z3581.USD","IE0002270589.USD","IE00BSNM7G36.USD","LU0889565916.HKD","BMED","BK4578","LU2468319806.SGD","SG9999015945.SGD","LU1934455863.HKD","LU2324357040.USD","LU1023059063.AUD","SG9999015978.USD","LU1674673428.USD","BK4139","BIB","TBXU","GILD","LU1061106388.HKD","BK4568","LU0965508806.USD","LU0289739699.SGD","LU0234570918.USD","BK4583","BK4585","IBB","IE00B3T34201.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185859812","title":"CHMP推薦吉利德Trodelvy®聯合Keytruda®用於PD-(L)1陽性一線轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1185859812","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185859812?lang=zh_tw&edition=fundamental","pubTime":"2026-07-24 18:29","pubTimestamp":1784888958,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用药品委员会（CHMP）近日给出推荐意见，支持吉利德科学的Trodelvy®与Keytruda®联合使用，用于治疗PD-(L)1阳性的一线转移性三阴性乳腺癌患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE00B3T34201.USD","IBBQ","LU0058720904.USD","LU0823416689.USD","LU0965509010.AUD","BK4532","LU0965509283.SGD","LU1585245621.USD","LU1934455194.USD","LU1674673428.USD","LU1061106388.HKD","LU2087621335.USD","LU1057294990.SGD","BK4550","BK4588","LU0109394709.USD","BK4578","LU1934455277.USD","MEDI","BBH","IBB","LU1066051498.USD","LU0882574055.USD","LU1037948541.HKD","GILD","IE00BSNM7G36.USD","BK4583","BK4566","BK4585","BIB","LU1674673691.USD","LU2468319806.SGD","LU0289739699.SGD","LU1934455863.HKD","SG9999015986.USD","TMED","IE00BKVL7J92.USD","LU0965508806.USD","BK4139","LU1430594728.SGD","LU1571399168.USD","SG9999015945.SGD","LU0889565916.HKD","SG9999015978.USD","LU2112291526.USD","BK4568","LU0234570918.USD","IE00B19Z3581.USD","LU0861579265.USD","LU0965509101.SGD","LU0122379950.USD","LU2324357040.USD","LU1778281490.HKD","LU1023059063.AUD","BMED","LU1037948897.HKD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU1839511570.USD","LU0320765992.SGD","TBXU","LU1066053197.SGD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653074709","title":"百濟神州/安進 FIC 雙抗，皮下製劑進入 III 期","url":"https://stock-news.laohu8.com/highlight/detail?id=2653074709","media":"新浪医药","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653074709?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 19:30","pubTimestamp":1784806200,"startTime":"0","endTime":"0","summary":"7 月 22 日，药物临床试验登记与信息公示平台显示，安进和百济神州共同登记了一项在接受含铂一线化疗后的复发性广泛期小细胞肺癌试验参与者中比较 Tarlatamab皮下给药与静脉给药的 III 期研究DeLLphi-315。在皮下剂型的开发方面，安进和百济神州于 2024 年 9 月启动了一项在广泛期小细胞肺癌受试者中评价 Tarlatamab 皮下给药的安全性、耐受性、药代动力学和初步抗肿瘤活性的 Ib 期研究 DeLLphi-308。而本次启动的DeLLphi-315 研究是塔拉妥单抗皮下给药方案启动的首个 III 期临床试验。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-07-23/doc-iniivazc5268721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06160","LU1770034418.SGD","BK1583","688235","IE0009355771.USD","IBB","BK1500","BBH","BK4534","IE00BFTCPJ56.SGD","LU0289739699.SGD","BK4588","LU2112291526.USD","LU2468319806.SGD","LU0889565916.HKD","KURE","IE00BJT1NW94.SGD","BIB","IE00B4R5TH58.HKD","LU1303224171.USD","BK4599","ONC","LU1251922891.USD","PJP","LU1969619763.USD","LU0588546209.SGD","LU0122379950.USD","BK1588","SG9999001440.SGD","LU0307460666.USD","IBBQ","LU0058720904.USD","LU1061106388.HKD","LU2328871848.SGD","LU0320765992.SGD","BK4581","BK4585","III","LU2242652126.USD","LU2242646821.SGD","AMGN","BK4134","LU0868494617.USD","TBXU","LU1719994722.HKD","LU1571399168.USD","PBE","LU1983299246.USD","IE0002141913.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653749341","title":"argenx(ARGX)二季度產品淨銷售額達15.16億美元 按年增長60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653749341","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653749341?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 18:18","pubTimestamp":1784801894,"startTime":"0","endTime":"0","summary":"金吾财讯 | 全球自身免疫疾病龙头生物科技公司 argenx 发布了2026年第二季度及上半年财报。其中，2026年第二季度，公司实现产品净销售额 15.16亿美元，同比大幅增长 60%，环比增长 17%。资金储备方面，截至2026年6月30日，argenx 拥有的现金、现金等价物及流动金融资产达 52亿美元，显著高于2025年底的44亿美元，为后续临床研发及商业化扩张提供了雄厚的资金屏障。截至2026年底，argenx 预计将有10款药物分子处于临床研发阶段。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/ODM0ODU4NWZiOGY2NDQ4NTA4OTM0NDg5MTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ODM0ODU4NWZiOGY2NDQ4NTA4OTM0NDg5MTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302939","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","LU2324357040.USD","TBXU","BK4585","LU0889565916.HKD","BK4505","FMED","LU1983260115.SGD","IE0034235188.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4588","ARGX","IBB","IE00BJT1NW94.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653712957","title":"美國研究綜述-Alphabet、IBM、特斯拉","url":"https://stock-news.laohu8.com/highlight/detail?id=2653712957","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653712957?lang=zh_tw&edition=fundamental","pubTime":"2026-07-23 15:30","pubTimestamp":1784791811,"startTime":"0","endTime":"0","summary":"美国研究综述-Alphabet、IBM、特斯拉路透7月23日-周四，华尔街证券分析师调整了包括Alphabet、IBM和特斯拉在内的多家美国上市公司评级及目标股价。股票按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nL4T43P0KW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DIG","GILD","BLFS","FTNT","PSX","EWBC","IBM","BAI","AMD","EFX","GOOX","NTRS","RJF","CVX","GOOGL","SEIC","CVNA","AMDS","WUGI","CASH","MCB","SF","BMI","ARTY","KDP","MPC","SKYY","GOOW","IPAR","CDNA","KNX","T","BP","GSHD","CCI","PEGA","NOC","IBB","ARWR","EOG","CLIX","SNDK","EFIV","FTAI","CME","MNPR","XOM","GEV","ROL","CELH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653618768","title":"數據簡報-邦迪布吉奧埃博拉病毒：正在研發哪些疫苗和治療方法","url":"https://stock-news.laohu8.com/highlight/detail?id=2653618768","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653618768?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 20:52","pubTimestamp":1784724736,"startTime":"0","endTime":"0","summary":"数据简报-邦迪布吉奥埃博拉病毒：正在研发哪些疫苗和治疗方法更新疫情数据，补充临床试验进展及诊断检测详情Mariam Sunny/Jennifer Rigby路透7月22日-全球卫生部门正争分夺秒地寻找医疗方案，以遏制刚果民主共和国东部由邦迪布吉奥 埃博拉病毒株引发的疫情。与更常见的扎伊尔毒株不同，目前尚无针对邦迪布吉奥毒株的获批疫苗或治疗方法。据该公司称，实验室研究表明该药物对邦迪布吉奥埃博拉病毒具有活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4T43O1A0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU3187612489.SGD","LU0310800379.SGD","LU0738911758.USD","LU1323610961.USD","LU0158827948.USD","LU0965509010.AUD","LU1037948897.HKD","LU1019634622.SGD","IE00B19Z3B42.SGD","LU1023059063.AUD","SG9999014575.USD","IE00BN8TJ469.HKD","688317","LU0109394709.USD","LU0114720955.EUR","LU0171293334.USD","LU2133065610.SGD","LU0266013472.USD","LU0784385170.HKD","LU0052756011.USD","LU0499090636.EUR","BK4583","LU1291159041.SGD","LU0130102774.USD","LU2091194634.USD","IYH","LU1051770623.HKD","LU0823434740.USD","LU1674673691.USD","TBXU","LU1084165304.USD","IBB","SGXZ57979304.SGD","LU0640478417.SGD","LU1863844749.USD","BK4568","LU1153584641.USD","IE00B4R5TH58.HKD","LU2362540622.SGD","LU0827474353.SGD","LU0708994859.HKD","LU1814569148.SGD","LU1261432733.SGD","LU0238689110.USD","FTXH","LU1934455194.USD","BK4559","MRNY","LU0203345920.USD","HRTS","LU0792757196.USD","LU0823416689.USD","LU0997586432.USD","LU1093756325.SGD","IE00BKVL7J92.USD","LU0234572021.USD","SG9999001176.USD","LU0976567544.SGD","BK4578","IE00BZ1G4Q59.USD","LU1267930573.SGD","LU1003077747.HKD","LU0390134368.USD","REGN","BIB","LU1066051811.HKD","LU2293690249.USD","IE0009355771.USD","LU1778281490.HKD","BK4550","IE00BLSP4239.USD","AZN.UK","LU1066051498.USD","LU2106854487.HKD","LU2125154935.USD","LU1974910355.USD","IE000M9KFDE8.USD","LU2125909247.SGD","LU0496365809.HKD","FHLC","LU2362541513.USD","LU1989771016.USD","LU1057294990.SGD","LU2089984988.USD","LU0047473722.SGD","OSUR","SG9999015358.SGD","BK4534","LU1989772923.USD","MRNX","LU0265550946.USD","IE00BFTCPJ56.SGD","SG9999015952.SGD","LU0920840948.USD","LU0887340254.USD","IE00B19Z3581.USD","LU2539964713.USD","LU1934455277.USD","LU1923622614.USD","LU0784385840.USD","IE0002270589.USD","LU0171276677.USD","LU1037948541.HKD","LU1019632923.USD","LU2237443895.HKD","LU1064927863.SGD","LU0006306889.USD","LU0098860793.USD","SG9999015945.SGD","BK5011","LU1153585028.USD","LU0208291251.USD","LU1674673428.USD","LU1046234339.USD","LU1061106388.HKD","IE00B1BXHZ80.USD","LU0985320562.USD","IE00BLSP4452.SGD","WDNA","LU1066051225.USD","LU2468319806.SGD","LU2125909593.SGD","GNOM","TMED","LU2324357040.USD","SG9999014559.SGD","LU0889565080.SGD","LU0477156953.USD","LU0859254822.USD","LU2023250504.SGD","BK4501","LU2125154778.USD","LU1839511570.USD","LU1941712348.USD","LU2491050071.SGD","LU0868494708.USD","LU0972486137.USD","LU0965509101.SGD","LU0128525689.USD","IDNA","LU1941712264.USD","LU0963555726.SGD","LU0980610538.SGD","LU1863844665.USD","LU0053666078.USD","LU0310799852.SGD","SG9999015986.USD","LU0823399737.USD","SG9999002224.SGD","LU1829250122.USD","SG9999001176.SGD","LU2023250843.SGD","LU1989772840.SGD","LU1116320737.USD","LU2237438978.USD","PAWZ","LU0964806797.USD","LU1170363599.USD","LU2087621335.USD","LU2360032135.SGD","SG9999013999.USD","LU0203347892.USD","LU0106261372.USD","BK4007","LU2237443978.SGD","LU0757432116.USD","IHE","LU0857590862.USD","LU1496350502.SGD","LU0077335932.USD","LU0310800965.SGD","LU0553294199.USD","LU1078025761.USD","LU0689626769.HKD","LU0823434583.USD","LU1880407132.USD","LU2089283258.USD","LU1015430645.USD","LU1267930227.SGD","IE00BJJMRZ35.SGD","GDOC","LU0661504455.SGD","LU0124676726.USD","LU1496350171.SGD","BBH","LU1934455863.HKD","LU0861579265.USD","LU1487256676.USD","LU1196032939.SGD","BK0239","LU1066053197.SGD","LGHT","LU0575583348.USD","LU0545039389.USD","BK4551","LU0889566641.SGD","LU0949170772.SGD","PPH","BMED","LU0029864427.USD","LU1301847155.USD","SG9999014542.SGD","LU0784383803.USD","MEDI","IE0034235188.USD","LU0122379950.USD","LU0969580561.USD","LU2293690082.USD","LU1880407215.USD","LU0882574055.USD","LU1929549753.HKD","LU0526926950.USD","LU1699723380.USD","BK4198","LU0784384876.USD","LU1481600234.SGD","BK4548","LU0965508806.USD","JDOC","TRUH","LU1355424745.HKD","LU2355687059.USD","LU1201861249.SGD","SG9999015341.SGD","LU2108987350.USD","LU0011850046.USD","MRNA","LU0070302665.USD","LU1069347547.HKD","LU1917777945.USD","LU0949170426.SGD","LU0920783379.SGD","GILD","LU1119994496.HKD","LU1003076772.USD","LU0211331839.USD","XLV","LU2023251221.USD","LU2114397693.USD","LU1430594728.SGD","LU2357627491.SGD","LU2491050154.USD","IE00BKPKM643.USD","IE00B7SZLL34.SGD","VHT","IBBQ","LU2461242641.AUD","LU2362541273.HKD","LU2361044865.SGD","LU2361044949.HKD","LU0957799991.USD","SG9999002232.USD","LU0345777147.USD","LU0320765992.SGD","IE00BSNM7G36.USD","LU1093756168.USD","LU2237443382.USD","LU1983299246.USD","LU0345777659.USD","LU1273509221.SGD","MRK","LU0960981461.USD","BK4566","LU1035773651.USD","LU0965509283.SGD","SG9999001440.SGD","LU2237443622.USD","LU1481599808.USD","LU1571399168.USD","LU2237443465.HKD","BK4139","LU0211327993.USD","LU0211328371.USD","LU2279689827.SGD","LU0058720904.USD","LU0265550359.USD","LU0432979614.USD","LU1104425308.USD","LU0320765489.SGD","LU2112291526.USD","LU1267930490.SGD","BK4532","SG9999015978.USD","LU0889565916.HKD","LU0557290698.USD","IXJ","LU0128525929.USD","IE00BJT1NW94.SGD","LU2361045086.USD","LU1162221912.USD","LU0211326839.USD","SG9999014567.USD","BK4585","BK4516","LU1585245621.USD","IE00B3T34201.USD","IE0002141913.USD","LU0320765646.SGD","LU0648001328.SGD","LU2089284900.SGD","LU0289739699.SGD","LU0130517989.USD","BK4533","LU1116320901.HKD","LU0211326755.USD","LU0234570918.USD","RXL","LU0047473722.EUR","LU2491049909.HKD","LU0868494617.USD","03165","LU2433249047.HKD","LU0942090050.USD","BK4588","LU2237443549.SGD","LU0997586515.USD","LU1267930813.SGD","IE00B2B36J28.USD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653584157","title":"創新藥研發加速遇「猴荒」","url":"https://stock-news.laohu8.com/highlight/detail?id=2653584157","media":"三里河","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653584157?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 16:21","pubTimestamp":1784708497,"startTime":"0","endTime":"0","summary":"“要站在‘猴’里，不要像猴子一样站在那里。”资本市场从来不缺故事。近期，昭衍新药业绩暴增，原因是实验猴市场价格上涨，带动公司手里的“猴子资产”大幅增值，多家相关概念公司股价也跟风大涨。甚至有人顺藤摸瓜，挖出了“香蕉概念”。网友戏称：这是产业链挖掘最深的一次。一只猴子，为什么能扰动资本市场？答案藏在药物的研发链条里。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607223817277458.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607223817277458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["WRND","APXH","BIOY","SBIO","BBP","GSKH","IBB","LFSC","BK4588","GDOC","PBE","XLVI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653204798","title":"吉利德與默克聯合研發的每周服用一次的艾滋病口服藥在晚期臨床試驗中成功抑制了病毒","url":"https://stock-news.laohu8.com/highlight/detail?id=2653204798","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653204798?lang=zh_tw&edition=fundamental","pubTime":"2026-07-22 01:23","pubTimestamp":1784654592,"startTime":"0","endTime":"0","summary":"吉利德与默克联合研发的每周服用一次的艾滋病口服药在晚期临床试验中成功抑制了病毒路透7月21日-吉利德科学公司和默克公司周二表示，其正在试验中的每周服用一次的艾滋病毒口服药在两项晚期临床试验中成功抑制了病毒，这为该药的监管申报提供了支持，该疗法有望成为此类疾病治疗中首个此类方案。默克公司的每日一次艾滋病口服复方制剂Idvynso已于4月获得美国食品药品监督管理局批准 ，为艾滋病患者提供了另一种治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1N1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","LU1983299246.USD","LU2089984988.USD","TRUH","SG9999014542.SGD","IBBQ","LU0058720904.USD","PPH","MRK","IXJ","LU2087621335.USD","IE00B2B36J28.USD","TBXU","IE00BJJMRZ35.SGD","MEDI","LU1989771016.USD","BBH","IBB","LU0868494708.USD","LU1093756168.USD","GILD","PAWZ","VHT","HRTS","RXL","BIB","LU1929549753.HKD","GDOC","FTXH","TMED","LU0889565916.HKD","LU2023250843.SGD","XLV","FHLC","SG9999001176.USD","IHE","LU0861579265.USD","LU1291159041.SGD","LU2324357040.USD","LU0432979614.USD","LU0266013472.USD","LU1778281490.HKD","LU1023059063.AUD","BMED","LU1699723380.USD","LU1941712348.USD","JDOC","LU1066053197.SGD","LU1923622614.USD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653206285","title":"安進就股東提起的指控其隱瞞107億美元税單的訴訟達成和解","url":"https://stock-news.laohu8.com/highlight/detail?id=2653206285","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653206285?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 23:07","pubTimestamp":1784646437,"startTime":"0","endTime":"0","summary":"安进就股东提起的指控其隐瞒107亿美元税单的诉讼达成和解Jonathan Stempel路透纽约7月21日-安进公司就一起指控其延迟披露可能因六年税款申报不足而需向美国国税局补缴107亿美元的诉讼，达成了一项7400万美元的和解协议。安进否认有任何不当行为，并于周二表示仍认为这些指控毫无依据。美国国税局就安进公司所谓的“转让定价”做法，要求其补缴87亿美元税款及利息，并处以20亿美元罚款。安进公司表示，美国税务法院的裁决可能于今年作出。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nL4T43N1GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU1983299246.USD","BK4534","IE0009355771.USD","BIB","LU2089984988.USD","BK4139","IBB","LU0109394709.USD","LU0058720904.USD","LU2242652126.USD","SG9999001440.SGD","BK4599","IE00BFTCPJ56.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU1571399168.USD","LU1057294990.SGD","BBH","LU1061106388.HKD","LU2242646821.SGD","BK4585","IE0002141913.USD","BK4588","IE00BJT1NW94.SGD","LU2112291526.USD","PJP","BK4566","LU0868494617.USD","LU0289739699.SGD","LU0122379950.USD","TBXU","PBE","AMGN","BK4581","LU2468319806.SGD","IBBQ","IE00B2B36J28.USD","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169878111","title":"Leerink Partners下調吉利德科學評級至「與大盤持平」，目標價大幅調降至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1169878111","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169878111?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 12:03","pubTimestamp":1784606620,"startTime":"0","endTime":"0","summary":"投资银行Leerink Partners调整了对生物技术公司吉利德科学的股票评级。该机构将其评级从原先的“跑赢大盘”下调至“与大盘持平”，反映出其对该公司近期前景更为审慎的看法。\n与此同时，Leerink Partners也显著下调了吉利德科学的目标股价，从每股146美元大幅削减至127美元。这一调整意味着该机构对该公司未来股价的预期有所降低。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","IE00B19Z3B42.SGD","LU0109394709.USD","LU1934455277.USD","LU2089984988.USD","GILD","LU0882574055.USD","SG9999015952.SGD","BK4550","LU0058720904.USD","LU0122379950.USD","LU0234570918.USD","LU1023059063.AUD","BK4583","LU1037948897.HKD","LU1066053197.SGD","BK4139","LU1674673691.USD","LU0965509010.AUD","BK4566","LU0114720955.EUR","LU0823416689.USD","IE00B7SZLL34.SGD","LU1066051498.USD","LU2087621335.USD","LU1571399168.USD","LU2468319806.SGD","IE00BSNM7G36.USD","IE00BZ1G4Q59.USD","LU0861579265.USD","MEDI","LU1778281490.HKD","TBXU","LU1061106388.HKD","LU0889565916.HKD","LU0965508806.USD","LU0965509283.SGD","LU1934455194.USD","LU1839511570.USD","LU1934455863.HKD","LU0289739699.SGD","BK4532","IBBQ","IBB","LU0320765992.SGD","LU0965509101.SGD","LU1674673428.USD","BK4568","SG9999015978.USD","LU1430594728.SGD","SG9999015945.SGD","IE0002270589.USD","LU1057294990.SGD","LU2112291526.USD","SG9999015986.USD","IE00BKVL7J92.USD","TMED","IE00B3T34201.USD","IE00B19Z3581.USD","BK4585","LU1037948541.HKD","BBH","LU1585245621.USD","BK4588","BK4578","BMED","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653210240","title":"Leerink下調吉利德科學目標價至127美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653210240","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653210240?lang=zh_tw&edition=fundamental","pubTime":"2026-07-21 10:35","pubTimestamp":1784601350,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0965509101.SGD","LU1585245621.USD","LU0965509283.SGD","MEDI","LU0882574055.USD","IBBQ","LU0058720904.USD","LU0861579265.USD","IE00BKVL7J92.USD","UUP","LU1934455863.HKD","LU2112291526.USD","LU0122379950.USD","LU0889565916.HKD","SG9999015986.USD","BK4578","LU0289739699.SGD","LU1839511570.USD","IE00BZ1G4Q59.USD","LU1037948541.HKD","SG9999015945.SGD","IE00BSNM7G36.USD","BBH","BK4550","LU2087621335.USD","LU1674673428.USD","IBB","LU1066053197.SGD","BMED","LU1674673691.USD","LU0109394709.USD","IE00B7SZLL34.SGD","BK4585","GILD","LU0320765992.SGD","BK4139","LU2089984988.USD","LU2324357040.USD","UDN","LU0234570918.USD","LU0965509010.AUD","LU1023059063.AUD","LU0114720955.EUR","BK4583","IE00B19Z3B42.SGD","LU1778281490.HKD","SG9999015978.USD","LU2468319806.SGD","LU0823416689.USD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652423028","title":"Kalshi將允許對臨床試驗和FDA決定進行投注","url":"https://stock-news.laohu8.com/highlight/detail?id=2652423028","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652423028?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 23:59","pubTimestamp":1784217550,"startTime":"0","endTime":"0","summary":"Kalshi将允许对临床试验和FDA决定进行投注路透7月16日-预测市场平台Kalshi周四表示，将开始接受针对临床试验结果和美国食品药品监督管理局监管审查结果的投注，这标志着药物研发的赔率首次向公众公开。Kalshi表示，这些市场允许投资者针对单一药物而非整个公司进行投注。Kalshi和AppliedXL将在试验完成受试者招募后才发布相关合约。Kalshi平台于2021年上线，允许用户对体育赛事、选举结果和天气等事件进行投注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nL4S43I1IP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","LU1061106388.HKD","IE00B7SZLL34.SGD","LU0122379950.USD","LU0058720904.USD","LU2468319806.SGD","LU0861579265.USD","LU0889565916.HKD","LU0965509283.SGD","SG9999015952.SGD","BIB","SG9999015945.SGD","BK4588","BK4532","LU1839511570.USD","LU2112291526.USD","BK4578","GILD","LU1066051498.USD","LU1674673691.USD","LU0109394709.USD","IE0002270589.USD","LU1585245621.USD","LU1037948897.HKD","LU1057294990.SGD","LU0823416689.USD","SMMT","LU0965508806.USD","IBB","SG9999015978.USD","LU0882574055.USD","BBH","IBBQ","MEDI","LU2089984988.USD","BK4566","LU1934455863.HKD","IE00B19Z3B42.SGD","LU2087621335.USD","LU2324357040.USD","LU1934455277.USD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU1037948541.HKD","BK4583","BK4585","LU1571399168.USD","LU0114720955.EUR","BMED","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651495621","title":"三星生物製劑與歐加農將在澳大利亞推出新型生物類似藥。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651495621","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651495621?lang=zh_tw&edition=fundamental","pubTime":"2026-07-16 04:04","pubTimestamp":1784145897,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LU2272731865.HKD","LU2322448791.USD","IE00B5TLWC47.USD","LU1992135399.USD","PPH","LU1992135472.HKD","EMXC","LU2322448957.HKD","LU2473716301.USD","LU2272731782.SGD","LU2272731600.USD","XPH","IBB","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105068","title":"剛果啓動吉利德實驗性抗病毒藥物邦迪布吉奧埃博拉病毒試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105068","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105068?lang=zh_tw&edition=fundamental","pubTime":"2026-07-14 20:47","pubTimestamp":1784033246,"startTime":"0","endTime":"0","summary":"刚果启动吉利德实验性抗病毒药物邦迪布吉奥埃博拉病毒试验路透7月14日-刚果民主共和国的研究人员周二表示，他们已开始招募受试者，参与一项临床试验，测试吉利德科学公司GILD.O旗下实验性抗病毒药物奥贝德西韦作为刚果和乌干达当前邦迪布吉奥埃博拉疫情的暴露后治疗药物。在临床前研究中，奥贝德西韦已显示出对丝状病毒的活性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nL4S43G1EN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0289739699.SGD","IE00B3T34201.USD","BK4585","LU1934455863.HKD","LU1571399168.USD","LU1934455194.USD","BK4583","LU0965509283.SGD","GILD","BK4532","LU0320765992.SGD","LU1023059063.AUD","LU2324357040.USD","LU1430594728.SGD","MEDI","LU1674673691.USD","LU1778281490.HKD","BK4588","BIB","LU0114720955.EUR","LU0861579265.USD","IE0002270589.USD","LU0965509010.AUD","SG9999015978.USD","LU1839511570.USD","LU0234570918.USD","LU0823416689.USD","SG9999015986.USD","IE00BKVL7J92.USD","LU2468319806.SGD","BK4550","BK4566","LU1066053197.SGD","BBH","BMED","LU2089984988.USD","BK4578","LU1585245621.USD","IE00BZ1G4Q59.USD","LU1934455277.USD","IBB","LU1057294990.SGD","LU0965508806.USD","LU2087621335.USD","LU1061106388.HKD","IE00BSNM7G36.USD","LU1037948897.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651117599","title":"Vertex(VRTX)百億美元收購罕見病藥企 拓寬內分泌管線佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2651117599","media":"金吾财讯","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651117599?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 22:10","pubTimestamp":1783951848,"startTime":"0","endTime":"0","summary":"金吾财讯 | Vertex Pharmaceuticals 与 Crinetics Pharmaceuticals 共同披露收购协议，企业将以每股 85 美元现金完成标的全额收购，交易对应 Crinetics 整体股权价值约 100 亿美元，扣除标的账面现金后净交易对价 88 亿美元，交易预计 2026 年第三季度完成，消息落地后 Crinetics 盘后股价实现翻倍上涨。Vertex 计划依托自有现金搭配债务工具完成交易资金筹措，美国银行、摩根士丹利提供 45 亿美元全额过渡性融资，收购落地后企业罕见病内分泌赛道产品矩阵将实现大幅扩容。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/NjJmZjg2MTAxNTM3NTgyMzkx.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302497","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0234570918.USD","IE00B2B36J28.USD","CRNX","IE0002141913.USD","LU2456880835.USD","IBBQ","LU2362541513.USD","BBH","SG9999001176.USD","LU0757428866.USD","VERX","BIB","BK4588","LU1069344957.HKD","LU1585245621.USD","IE00BJT1NW94.SGD","LU1674673428.USD","IE00BFTCPJ56.SGD","LU2237438978.USD","IE00BZ9MQY76.HKD","IE00B4R5TH58.HKD","LU0061475181.USD","IBB","LU1093756325.SGD","IDNA","LU0566484027.USD","IE0002270589.USD","BK4007","IE0009355771.USD","LU2362540622.SGD","LU2417539215.USD","LU0889565916.HKD","SG9999013999.USD","LU0256863811.USD","PBE","LU0109394709.USD","LU1093756168.USD","LU1778281490.HKD","IE00B894F039.SGD","SG9999001176.SGD","VRTX","LU0432979614.USD","LU2362541273.HKD","LU0079474960.USD","IE00B19Z3581.USD","LU1035775433.USD","BK4585","IE00B19Z9Z06.USD","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183275253","title":"Pliant Therapeutics任命Flavia Borellini博士和Robert Iannone博士加入董事會","url":"https://stock-news.laohu8.com/highlight/detail?id=1183275253","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183275253?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 20:35","pubTimestamp":1783946106,"startTime":"0","endTime":"0","summary":"临床阶段生物技术公司Pliant Therapeutics今日宣布，任命Flavia Borellini博士与Robert Iannone博士为公司董事会新成员。这两项任命为董事会注入了深厚的全球肿瘤药物开发经验，并进一步强化了其在运营与监管事务方面的专业能力。目前，除了在Pliant任职外，他还担任Autolus Therapeutics的董事会成员。关于Pliant Therapeutics, Inc.：Pliant Therapeutics是一家临床阶段的生物制药公司，专注于基于整合素的疗法的发现与开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LENZ","BK4232","BK4139","R","IBB","BK4007","BK4022","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651711531","title":"RBC將Kymera Therapeutics的評級下調至「與行業持平」，並上調目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2651711531","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651711531?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 18:52","pubTimestamp":1783939974,"startTime":"0","endTime":"0","summary":"BUZZ-RBC将Kymera Therapeutics的评级下调至“与行业持平”，并上调目标价7月13日-** RBC资本市场将Kymera Therapeutics（KYMR.O）的评级从“跑赢大盘”下调至“与行业持平”，同时将其目标价从106美元上调至115美元** RBC表示，Kymera的KT-621是一种用于治疗中重度嗜酸性粒细胞性哮喘的每日一次实验性口服药，其在临床终点和生物标志物方","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4T43F0TY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","LU0889565916.HKD","BBH","LU2237438978.USD","IBBQ","LU0320765992.SGD","KYMR","LU2023250504.SGD","LU1917777945.USD","LU0882574055.USD","IBB","LU0823416689.USD","BK4585","LU0114720955.EUR","BK4139","REGN","LU2089984988.USD","LU2362540622.SGD","LU0289739699.SGD","LU0053666078.USD","LU0058720904.USD","LU2362541273.HKD","LU2468319806.SGD","BK4588","LU0109394709.USD","LU2362541513.USD","LU0823434740.USD","LU1974910355.USD","LU0823434583.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651162210","title":"英硅智能早盤升逾7% 與康哲藥業達成AI+創新藥研發新合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2651162210","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651162210?lang=zh_tw&edition=fundamental","pubTime":"2026-07-13 10:02","pubTimestamp":1783908120,"startTime":"0","endTime":"0","summary":" 英硅智能早盘涨超7%，截至发稿，股价上涨6.21%，报45.48港元，成交额3.32亿港元。 7月13日，据英硅智能官微消息，公司宣布与康哲药业在中枢神经系统领域开展另一项AI驱动的药物发现合作。 根据合作协议，双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，双方共同推进该研发项目的合作开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-13/doc-inihrnpk9058117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["VTHR","WRND","SG9999015952.SGD","SG9999015986.USD","AIPO","BK1593","GDOC","IE00BGHQDM52.EUR","00867","SG9999015978.USD","IBB","AGIX","SG9999015945.SGD","LFSC","SG9999004220.SGD","CHAT","BBP","SBIO","BK1191","LU2488822045.USD","ARTY","IE00BMCWC346.EUR","IE00BYV24P56.USD","BK4585","BK4588","IE00BVYPNP33.GBP","IE00BVYPNQ40.USD","GSKH","PBE","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650760159","title":"福泰製藥百億美元併購透露了什麼訊號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2650760159","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650760159?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 22:55","pubTimestamp":1783781749,"startTime":"0","endTime":"0","summary":"01百亿美元级现金并购的底气福泰制药2025年全年营收120.01亿美元，同比增长9%，非GAAP净利润47.5亿美元，毛利率维持85%以上高位，账面现金及有价证券超过123亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1783569458583958068","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["BK4588","LU0079474960.USD","BK4139","LU0234570918.USD","BK4567","IE00B2B36J28.USD","LU1093756168.USD","LU2462157665.USD","IE0002141913.USD","IE00B19Z9Z06.USD","IE00BJJMRZ35.SGD","LU2236285917.USD","IE00B894F039.SGD","LU1093756325.SGD","LU0823416689.USD","LU1778281490.HKD","LU2324357040.USD","SG9999001176.USD","IE0009355771.USD","LU0109394709.USD","LU1585245621.USD","IE00B19Z3581.USD","IE00BJT1NW94.SGD","LU0058720904.USD","KCE","XMMO","SG9999001176.SGD","IE0002270589.USD","IE00B19Z9P08.USD","BK4532","LU0320765992.SGD","LU1035775433.USD","LU1069344957.HKD","LU0289739699.SGD","IDNA","VRTX","LU2362540622.SGD","IE00BZ9MQY76.HKD","BIB","IBBQ","CALF","IE00BFTCPJ56.SGD","LU2417539215.USD","SGXZ57979304.SGD","LU0061475181.USD","IE00B4R5TH58.HKD","MYLD","BBH","PBE","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650131357","title":"吉利德科學(GILD)股票7月10日盤中下跌3.26%：關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2650131357","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650131357?lang=zh_tw&edition=fundamental","pubTime":"2026-07-11 00:16","pubTimestamp":1783700165,"startTime":"0","endTime":"0","summary":"• 吉利德科学股价在一项实体瘤三期临床试验失败后下跌。\n• 强劲的就业数据推高了美债收益率，令今日生物科技板块估值承压。\n• 由于肿瘤产品组合销售时间表推迟，分析师可能会下调其盈利预测。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262023383-market-movers-gild-20260710","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","LU0823416689.USD","BK4583","LU0965509101.SGD","LU1571399168.USD","LU1430594728.SGD","IE00B3T34201.USD","LU2112291526.USD","SG9999015952.SGD","BK4568","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU1674673691.USD","BIB","LU1066053197.SGD","IBBQ","LU1934455194.USD","BBH","LU2087621335.USD","LU2468319806.SGD","SG9999015986.USD","LU0882574055.USD","LU1934455863.HKD","LU0122379950.USD","BK4566","LU1037948541.HKD","LU0058720904.USD","LU1061106388.HKD","LU0965509283.SGD","LU1934455277.USD","IE00B19Z3581.USD","BK4550","LU0965508806.USD","IE00BZ1G4Q59.USD","MEDI","LU0289739699.SGD","LU0889565916.HKD","BK4578","LU2324357040.USD","LU1066051498.USD","LU1674673428.USD","BK4585","BK4588","IBB","BMED","BK4139","LU0861579265.USD","LU1057294990.SGD","LU0965509010.AUD","GILD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":6,"totalSize":150,"code":"91000000","status":"200"}]}}